問題一覧
1
Prescribing a serotonin reuptake inhibitor (SRI) to modulate serotonin levels and enhance inhibitory control over the amygdala
2
Serotonin, GABA, norepinephrine, and glutamate
3
Administering a selective serotonin reuptake inhibitor (SSRI) to modulate serotonin in the prefrontal cortex and reduce obsessive thoughts
4
Prefrontal Cortex → Striatum → Thalamus → Prefrontal Cortex; Dopamine, serotonin, norepinephrine
5
Administering a serotonin reuptake inhibitor (SRI) for the amygdala-centered circuit and implementing cognitive-behavioral therapy (CBT) to target the CSTC circuit’s prolonged worry
6
The amygdala-centered circuit initiates fear and phobias, while the CSTC circuit sustains anxious misery and obsessive worry
7
Enhancing serotonin levels to reduce amygdala reactivity and strengthening cognitive-behavioral techniques to improve ACC and OFC engagement
8
Anterior cingulate cortex (ACC) and orbitofrontal cortex (OFC)
9
Enhancing their ability to recognize and regulate affective symptoms, focusing on the emotional experience of fear
10
Affective symptoms focus on the emotional experience of fear, while autonomic symptoms prepare the body to take action
11
Engaging the patient in grounding exercises to reduce the urge for physical action and keep them present
12
Affective symptoms remain within the psychological realm, while motor symptoms engage the body for action
13
Encouraging mindfulness-based stress reduction to help decrease hypothalamic activation and cortisol release
14
Hypothalamic-pituitary-adrenal (HPA) axis
15
Implementing stress management techniques to reduce hypothalamic activation and the risk of CAD, DM, and stroke
16
Endocrine symptoms involve cortisol release and prolonged stress responses affecting multiple systems, while motor symptoms involve immediate physical actions through the PAG
17
Implementing relaxation techniques to reduce activation of the locus coeruleus, thus lowering heart rate and blood pressure
18
Locus coeruleus in the pons
19
Implementing deep breathing exercises to modulate autonomic arousal and lower heart rate and blood pressure
20
Cardiovascular symptoms sustain readiness via autonomic pathways, while motor symptoms involve voluntary pathways for immediate action
21
Encouraging controlled breathing exercises to regulate the influence of the parabrachial nucleus on respiratory patterns
22
Amygdala to parabrachial nucleus in the brainstem
23
Teaching controlled breathing techniques to specifically manage oxygen intake and reduce feelings of smothering
24
Respiratory symptoms enhance oxygen intake, while cardiovascular symptoms prepare circulatory readiness for rapid action
25
Cortico-striato-thalamo-cortical (CSTC) circuit, which includes the orbitofrontal cortex, caudate nucleus, thalamus, and prefrontal cortex
26
Cortico-striato-thalamo-cortical (CSTC) circuit
27
Orbitofrontal cortex (OFC)
28
Orbitofrontal cortex (OFC)
29
Caudate nucleus
30
Caudate nucleus
31
Thalamus
32
Thalamus
33
Targeting serotonin to manage anxiety and dopamine to help control compulsive behaviors
34
Serotonin and dopamine
35
Amygdala and prefrontal cortex
36
Amygdala
37
Prefrontal cortex (PFC)
38
Amygdala
39
Hippocampus
40
Hippocampus
41
Amygdala, periaqueductal gray (PAG), and insula
42
Increased activity in the amygdala, PAG, and insula explains the intense fear and physiological arousal characteristic of panic disorder.
43
Periaqueductal gray (PAG)
44
Periaqueductal gray (PAG)
45
Insula
46
Insula
47
Exposure therapy combined with interventions to decrease amygdala hyperactivity, helping the patient process trauma-related stimuli more calmly
48
Amygdala
49
Engaging in cognitive-behavioral therapy (CBT) to enhance prefrontal cortex function and improve emotional regulation
50
Prefrontal cortex
51
Exposure therapy to reduce cortisol levels and mitigate effects of chronic HPA-axis activation on memory
52
Hippocampus
53
Tailoring interventions based on the specific connectivity of the amygdala in each disorder, such as targeting generalized worry in GAD or trauma re-experiencing in PTSD
54
Hyperactivity related to fear processing
55
Utilizing exposure and response prevention therapy (ERP) to specifically target the CSTC circuit in the OCD patient, while focusing on amygdala-centered interventions for the GAD patient
56
The CSTC circuit is central to OCD, supporting repetitive thoughts and behaviors, while GAD and panic disorder rely more on amygdala-centered pathways
57
For GAD and PTSD, focusing on techniques that improve emotional regulation and reduce chronic worry; for OCD, implementing strategies that address overcontrol and hyperresponsiveness to perceived threats
58
In GAD and PTSD, it leads to difficulties with emotional regulation, while in OCD, it contributes to overcontrol and heightened threat response
59
Cognitive restructuring to reduce hypervigilance and prevent unnecessary HPA-axis activation
60
By temporarily increasing cortisol production, which enhances energy and alertness in response to immediate stress
61
Implementing mindfulness-based stress reduction to interrupt continuous HPA-axis activation and support hippocampal recovery
62
It impairs hippocampal function, affecting memory and reinforcing stress responses through heightened amygdala reactivity
63
Engaging in cognitive-behavioral therapy to reduce stress responses and protect hippocampal and amygdala function
64
Hypothalamus → Pituitary gland → Adrenal glands; chronic activation releases cortisol, impairing hippocampal function and increasing amygdala reactivity
65
Combining mindfulness-based stress reduction to manage HPA-axis activation and cognitive-behavioral therapy (CBT) to address the repetitive cognitive patterns of the CSTC
66
The HPA-axis involves neuroendocrine responses that reinforce anxiety physiologically, whereas the CSTC circuit perpetuates anxiety through cognitive patterns
Patho Renal
Patho Renal
Two Clean Queens · 100問 · 2年前Patho Renal
Patho Renal
100問 • 2年前Pathophysiology
Pathophysiology
Two Clean Queens · 100問 · 2年前Pathophysiology
Pathophysiology
100問 • 2年前Patho Immunology
Patho Immunology
Two Clean Queens · 34問 · 2年前Patho Immunology
Patho Immunology
34問 • 2年前Patho Hematology
Patho Hematology
Two Clean Queens · 100問 · 2年前Patho Hematology
Patho Hematology
100問 • 2年前Patho Hematology 2
Patho Hematology 2
Two Clean Queens · 76問 · 2年前Patho Hematology 2
Patho Hematology 2
76問 • 2年前Patho Respiratory
Patho Respiratory
Two Clean Queens · 100問 · 2年前Patho Respiratory
Patho Respiratory
100問 • 2年前Patho Respiratory 2
Patho Respiratory 2
Two Clean Queens · 54問 · 2年前Patho Respiratory 2
Patho Respiratory 2
54問 • 2年前Patho Cardiovascular
Patho Cardiovascular
Two Clean Queens · 100問 · 2年前Patho Cardiovascular
Patho Cardiovascular
100問 • 2年前Patho Cardiovascular 2
Patho Cardiovascular 2
Two Clean Queens · 56問 · 2年前Patho Cardiovascular 2
Patho Cardiovascular 2
56問 • 2年前Patho MSK
Patho MSK
Two Clean Queens · 52問 · 2年前Patho MSK
Patho MSK
52問 • 2年前Patho Acid Base
Patho Acid Base
Two Clean Queens · 35問 · 2年前Patho Acid Base
Patho Acid Base
35問 • 2年前Renal 2
Renal 2
Two Clean Queens · 10問 · 2年前Renal 2
Renal 2
10問 • 2年前Fluid Balance
Fluid Balance
Two Clean Queens · 43問 · 2年前Fluid Balance
Fluid Balance
43問 • 2年前Patho Endocrine
Patho Endocrine
Two Clean Queens · 100問 · 2年前Patho Endocrine
Patho Endocrine
100問 • 2年前Patho Endocrine 2
Patho Endocrine 2
Two Clean Queens · 42問 · 2年前Patho Endocrine 2
Patho Endocrine 2
42問 • 2年前Infections
Infections
Two Clean Queens · 58問 · 2年前Infections
Infections
58問 • 2年前Patho Shock
Patho Shock
Two Clean Queens · 31問 · 2年前Patho Shock
Patho Shock
31問 • 2年前GI
GI
Two Clean Queens · 100問 · 2年前GI
GI
100問 • 2年前GI 2
GI 2
Two Clean Queens · 18問 · 2年前GI 2
GI 2
18問 • 2年前Cancer
Cancer
Two Clean Queens · 54問 · 2年前Cancer
Cancer
54問 • 2年前問題一覧
1
Prescribing a serotonin reuptake inhibitor (SRI) to modulate serotonin levels and enhance inhibitory control over the amygdala
2
Serotonin, GABA, norepinephrine, and glutamate
3
Administering a selective serotonin reuptake inhibitor (SSRI) to modulate serotonin in the prefrontal cortex and reduce obsessive thoughts
4
Prefrontal Cortex → Striatum → Thalamus → Prefrontal Cortex; Dopamine, serotonin, norepinephrine
5
Administering a serotonin reuptake inhibitor (SRI) for the amygdala-centered circuit and implementing cognitive-behavioral therapy (CBT) to target the CSTC circuit’s prolonged worry
6
The amygdala-centered circuit initiates fear and phobias, while the CSTC circuit sustains anxious misery and obsessive worry
7
Enhancing serotonin levels to reduce amygdala reactivity and strengthening cognitive-behavioral techniques to improve ACC and OFC engagement
8
Anterior cingulate cortex (ACC) and orbitofrontal cortex (OFC)
9
Enhancing their ability to recognize and regulate affective symptoms, focusing on the emotional experience of fear
10
Affective symptoms focus on the emotional experience of fear, while autonomic symptoms prepare the body to take action
11
Engaging the patient in grounding exercises to reduce the urge for physical action and keep them present
12
Affective symptoms remain within the psychological realm, while motor symptoms engage the body for action
13
Encouraging mindfulness-based stress reduction to help decrease hypothalamic activation and cortisol release
14
Hypothalamic-pituitary-adrenal (HPA) axis
15
Implementing stress management techniques to reduce hypothalamic activation and the risk of CAD, DM, and stroke
16
Endocrine symptoms involve cortisol release and prolonged stress responses affecting multiple systems, while motor symptoms involve immediate physical actions through the PAG
17
Implementing relaxation techniques to reduce activation of the locus coeruleus, thus lowering heart rate and blood pressure
18
Locus coeruleus in the pons
19
Implementing deep breathing exercises to modulate autonomic arousal and lower heart rate and blood pressure
20
Cardiovascular symptoms sustain readiness via autonomic pathways, while motor symptoms involve voluntary pathways for immediate action
21
Encouraging controlled breathing exercises to regulate the influence of the parabrachial nucleus on respiratory patterns
22
Amygdala to parabrachial nucleus in the brainstem
23
Teaching controlled breathing techniques to specifically manage oxygen intake and reduce feelings of smothering
24
Respiratory symptoms enhance oxygen intake, while cardiovascular symptoms prepare circulatory readiness for rapid action
25
Cortico-striato-thalamo-cortical (CSTC) circuit, which includes the orbitofrontal cortex, caudate nucleus, thalamus, and prefrontal cortex
26
Cortico-striato-thalamo-cortical (CSTC) circuit
27
Orbitofrontal cortex (OFC)
28
Orbitofrontal cortex (OFC)
29
Caudate nucleus
30
Caudate nucleus
31
Thalamus
32
Thalamus
33
Targeting serotonin to manage anxiety and dopamine to help control compulsive behaviors
34
Serotonin and dopamine
35
Amygdala and prefrontal cortex
36
Amygdala
37
Prefrontal cortex (PFC)
38
Amygdala
39
Hippocampus
40
Hippocampus
41
Amygdala, periaqueductal gray (PAG), and insula
42
Increased activity in the amygdala, PAG, and insula explains the intense fear and physiological arousal characteristic of panic disorder.
43
Periaqueductal gray (PAG)
44
Periaqueductal gray (PAG)
45
Insula
46
Insula
47
Exposure therapy combined with interventions to decrease amygdala hyperactivity, helping the patient process trauma-related stimuli more calmly
48
Amygdala
49
Engaging in cognitive-behavioral therapy (CBT) to enhance prefrontal cortex function and improve emotional regulation
50
Prefrontal cortex
51
Exposure therapy to reduce cortisol levels and mitigate effects of chronic HPA-axis activation on memory
52
Hippocampus
53
Tailoring interventions based on the specific connectivity of the amygdala in each disorder, such as targeting generalized worry in GAD or trauma re-experiencing in PTSD
54
Hyperactivity related to fear processing
55
Utilizing exposure and response prevention therapy (ERP) to specifically target the CSTC circuit in the OCD patient, while focusing on amygdala-centered interventions for the GAD patient
56
The CSTC circuit is central to OCD, supporting repetitive thoughts and behaviors, while GAD and panic disorder rely more on amygdala-centered pathways
57
For GAD and PTSD, focusing on techniques that improve emotional regulation and reduce chronic worry; for OCD, implementing strategies that address overcontrol and hyperresponsiveness to perceived threats
58
In GAD and PTSD, it leads to difficulties with emotional regulation, while in OCD, it contributes to overcontrol and heightened threat response
59
Cognitive restructuring to reduce hypervigilance and prevent unnecessary HPA-axis activation
60
By temporarily increasing cortisol production, which enhances energy and alertness in response to immediate stress
61
Implementing mindfulness-based stress reduction to interrupt continuous HPA-axis activation and support hippocampal recovery
62
It impairs hippocampal function, affecting memory and reinforcing stress responses through heightened amygdala reactivity
63
Engaging in cognitive-behavioral therapy to reduce stress responses and protect hippocampal and amygdala function
64
Hypothalamus → Pituitary gland → Adrenal glands; chronic activation releases cortisol, impairing hippocampal function and increasing amygdala reactivity
65
Combining mindfulness-based stress reduction to manage HPA-axis activation and cognitive-behavioral therapy (CBT) to address the repetitive cognitive patterns of the CSTC
66
The HPA-axis involves neuroendocrine responses that reinforce anxiety physiologically, whereas the CSTC circuit perpetuates anxiety through cognitive patterns